Updated:
PROTO SCRIPT PHARMACEUTICAL CORP
PROTO SCRIPT PHARMACEUTICAL CORP is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001521420, and its reported...
Overview
PROTO SCRIPT PHARMACEUTICAL CORP is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001521420, and its reported industry is Services-Mailing, Reproduction, Commercial Art & Photography. In 10-K filed on 2017-09-20, it reported annual revenue of USD 788,960; net income of USD -7,182,722; total assets of USD 170,191 for the fiscal period ended 2016-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- PROTO SCRIPT PHARMACEUTICAL CORP
- Former names in filing history
- YANEX GROUP, INC. (2011-06-27 to 2016-10-06)
- Classification
- Company
- Industry (SIC)
- 7330 — Services-Mailing, Reproduction, Commercial Art & Photography
- Headquarters
- Rancho Cucamonga, CA, United States
- Incorporated in
- NV
- Fiscal year end
- December 31
- SEC CIK
- 0001521420
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2016USD | $788,960 | -$7.2M | $170,191 | $3,507 | — | |
| FY2016USD | — | -$33,143 | $11,750 | $11,750 | -$38,209 | |
| FY2015USD | — | -$45,180 | $1,019 | $1,019 | -$45,421 | |
| FY2014USD | — | -$38,259 | $13,540 | $13,540 | -$32,504 |
FY2016. Net income: shown as originally filed; later filings report different values for the same periods.
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 10-Q | FORM 10-Q | ||
| 10-Q | FORM 10-Q | ||
| 10-Q | FORM 10-Q | ||
| 8-K | FORM 8-K | ||
| 10-K/A | FORM 10-K/A | ||
| 8-K | FORM 8-K | ||
| 10-K | FORM 10-K | ||
| 8-K | FORM 8-K CURRENT REPORT | ||
| 10-Q | FORM 10-Q QUARTERLY REPORT | ||
| 10-Q | FORM 10-Q QUARTERLY REPORT | ||
| 8-K | FORM 8-K CURRENT REPORT | ||
| 10-K/A | FORM 10-K/A AMENDED ANNUAL REPORT |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research PROTO SCRIPT PHARMACEUTICAL CORP in Altss
Track this company’s investors, transactions and relationships in Altss.